Invention Grant
- Patent Title: Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
-
Application No.: US14387979Application Date: 2013-03-14
-
Publication No.: US10588857B2Publication Date: 2020-03-17
- Inventor: Jerome J. Schentag , Mohan Kabadi
- Applicant: Therabiome, LLC
- Applicant Address: US NJ Marlboro
- Assignee: Therabiome, LLC
- Current Assignee: Therabiome, LLC
- Current Assignee Address: US NJ Marlboro
- Agency: Goodwin Procer LLP
- International Application: PCT/US2013/031483 WO 20130314
- International Announcement: WO2013/148258 WO 20131003
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K39/00
Abstract:
The invention provides oral vaccine formulations which deliver an antigen in the vicinity of the distal ileum and the area of the ileal Brake and/or the appendix. These vaccines are useful in the treatment and/or prevention of variety of disorders, including viral and bacterial infections and cancers. Related methods of treatment which use the oral vaccine formulations of the invention are also provided.
Public/Granted literature
- US20150071994A1 GASTROINTESTINAL SITE-SPECIFIC ORAL VACCINATION FORUMULATIONS ACTIVE ON THE ILEUM AND APPENDIX Public/Granted day:2015-03-12
Information query
